Loading...
Publication
Conhecimento, comportamentos e atitudes dos profissionais de farmácia em relação aos medicamentos biossimilares
| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.36 MB | Adobe PDF |
Abstract(s)
Através dos avanços da biotecnologia e com a caducidade da patente de alguns dos principais medicamentos biológicos de alto custo, a produção de medicamentos biossimilares passou a ser possível e cada vez mais lucrativa para as empresas que os produzem. Um biossimilar é um medicamento biológico altamente semelhante a outro medicamento biológico já aprovado denominado “medicamento de referência” em termos de estrutura, atividade biológica, eficácia, perfil de segurança e imunogenicidade. Estes medicamentos biológicos oferecem novas opções de tratamento para várias patologias, como diabetes, doenças autoimunes e vários tipos de cancro. Os medicamentos biossimilares são ainda relativamente recentes no arsenal terapêutico quando comparados com os medicamentos de síntese química. Dadas as suas características e especificidades, este tipo de medicamentos exigem dos profissionais de saúde novos conhecimentos e competências práticas, de modo a poderem prescrever, informar e aconselhar para o melhor uso dos mesmos. O principal objetivo deste estudo é obter uma visão abrangente do conhecimento, comportamentos e práticas dos profissionais de farmácia comunitária ou hospitalar sobre os medicamentos biossimilares em Portugal. Para o efeito realizou-se uma revisão bibliográfica, bem como, um estudo observacional e transversal, numa amostra de Profissionais de Farmácia das áreas hospitalar e comunitária. A recolha de dados foi efetuada através de um questionário online. A amostra foi constituída por 105 indivíduos, maioritariamente mulheres (80%), com o grau de licenciatura (58,1%) e mestrado (41%), 63,8% são Técnicos Superiores de Farmácia e 33% são Farmacêuticos. Constatou-se que 70,5 % dos profissionais sabe o que é um medicamento biossimilar embora os resultados do conhecimento específico não seja tão assertivo. Em conclusão, o conhecimento dos indivíduos da amostra acerca dos medicamentos biossimilares é genericamente positivo, não existindo diferenças estatisticamente significativas entre as classes profissionais Técnicos Superiores de Farmácia e Farmacêuticos.
Through the advances in biotechnology and the patent expiration of some of the major high-cost biological medicines, the production of biossimilars has become possible and increasingly profitable for the companies that produce them. A biosimilar is a biological medicine highly similar to another biological medicine already approved called "reference medicine" in terms of structure, biological activity, efficacy, safety profile and immunogenicity. These biological medicines offer new treatment options for various conditions such as diabetes, autoimmune diseases and various types of cancer. Biosimilar drugs are still relatively recent in the therapeutic arsenal when compared to chemically synthesized drugs. Given their characteristics and specificities, this type of medicine requires the health professional’s new knowledge and practical skills, so that they can prescribe, inform and advise for the best use of them. The main objective of this study was to a bibliographic revision, and also, to obtain a comprehensive view of the knowledge, behaviors and practices of pharmacy community or hospital professionals on biosimilars medicines in Portugal. For this purpose, we performed an observational and cross-sectional study on a sample of Pharmacy Professionals from the hospital and community areas. Data collection was done through an online questionnaire. Our sample consisted of 105 individuals, mostly women (80%), with a bachelor's degree (58.1%) and a master's degree (41%), 63.8% were Senior Pharmacy Technicians and 33% were Pharmacists. We found that 70.5% of professionals know what a biosimilar drug is, although the results of specific knowledge are not so assertive. In conclusion, the knowledge of the individuals in our sample about biosimilar medications is generally positive, and there are no statistically significant differences between the professional classes of Pharmacy and Pharmacy Supervisors.
Through the advances in biotechnology and the patent expiration of some of the major high-cost biological medicines, the production of biossimilars has become possible and increasingly profitable for the companies that produce them. A biosimilar is a biological medicine highly similar to another biological medicine already approved called "reference medicine" in terms of structure, biological activity, efficacy, safety profile and immunogenicity. These biological medicines offer new treatment options for various conditions such as diabetes, autoimmune diseases and various types of cancer. Biosimilar drugs are still relatively recent in the therapeutic arsenal when compared to chemically synthesized drugs. Given their characteristics and specificities, this type of medicine requires the health professional’s new knowledge and practical skills, so that they can prescribe, inform and advise for the best use of them. The main objective of this study was to a bibliographic revision, and also, to obtain a comprehensive view of the knowledge, behaviors and practices of pharmacy community or hospital professionals on biosimilars medicines in Portugal. For this purpose, we performed an observational and cross-sectional study on a sample of Pharmacy Professionals from the hospital and community areas. Data collection was done through an online questionnaire. Our sample consisted of 105 individuals, mostly women (80%), with a bachelor's degree (58.1%) and a master's degree (41%), 63.8% were Senior Pharmacy Technicians and 33% were Pharmacists. We found that 70.5% of professionals know what a biosimilar drug is, although the results of specific knowledge are not so assertive. In conclusion, the knowledge of the individuals in our sample about biosimilar medications is generally positive, and there are no statistically significant differences between the professional classes of Pharmacy and Pharmacy Supervisors.
Description
Keywords
Medicamentos biológicos Medicamentos biossimilares Farmacovigilância Profissionais de farmácia Conhecimentos, atitudes e prática em saúde